qingshan wang - Related publications

neuroinflammation and neurodegeneration
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Lin Q, Hou S, Dai Y, Jiang N, Lin Y. Monascin exhibits neuroprotective effects in rotenone model of Parkinson's disease via antioxidation and anti-neuroinflammation. Neuroreport. 31: 637-643. PMID 32427711 DOI: 10.1097/WNR.0000000000001467   
2020 Haque A, Samantaray S, Knaryan VH, Capone M, Hossain A, Matzelle D, Chandran R, Shields DC, Farrand AQ, Boger HA, Banik NL. Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease. Experimental Neurology. 113315. PMID 32302678 DOI: 10.1016/j.expneurol.2020.113315   
2020 Haque A, Samantaray S, Knaryan VH, Capone M, Hossain A, Matzelle D, Chandran R, Shields DC, Farrand AQ, Boger HA, Banik NL. Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease. Experimental Neurology. 113315. PMID 32302678 DOI: 10.1016/j.expneurol.2020.113315   
2020 Yang Y, Kong F, Ding Q, Cai Y, Hao Y, Tang B. Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response. Biochemical and Biophysical Research Communications. PMID 32321640 DOI: 10.1016/j.bbrc.2020.03.097   
2020 Wang L, Cai X, Shi M, Xue L, Kuang S, Xu R, Qi W, Li Y, Ma X, Zhang R, Hong F, Ye H, Chen L. Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/keap1 pathway. European Journal of Medicinal Chemistry. 199: 112385. PMID 32402936 DOI: 10.1016/j.ejmech.2020.112385   
2020 Bellucci A, Bubacco L, Longhena F, Parrella E, Faustini G, Porrini V, Bono F, Missale C, Pizzi M. Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's Disease. Frontiers in Aging Neuroscience. 12: 68. PMID 32265684 DOI: 10.3389/fnagi.2020.00068   
2020 Serapide MF, L'Episcopo F, Tirolo C, Testa N, Caniglia S, Giachino C, Marchetti B. Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain an Prosurvival Axis. Frontiers in Aging Neuroscience. 12: 24. PMID 32226376 DOI: 10.3389/fnagi.2020.00024   
2020 Cheng XY, Biswas S, Li J, Mao CJ, Chechneva O, Chen J, Li K, Li J, Zhang JR, Liu CF, Deng WB. Human iPSCs derived astrocytes rescue rotenone-induced mitochondrial dysfunction and dopaminergic neurodegeneration in vitro by donating functional mitochondria. Translational Neurodegeneration. 9: 13. PMID 32345341 DOI: 10.1186/s40035-020-00190-6   
2020 Atsushi T, Tamano H. New insight into Parkinson's disease pathogenesis from reactive oxygen species-mediated extracellular Zn influx. Journal of Trace Elements in Medicine and Biology : Organ of the Society For Minerals and Trace Elements (Gms). 61: 126545. PMID 32438294 DOI: 10.1016/j.jtemb.2020.126545   
2020 di Caudo C, Martínez-Valbuena I, Mundiñano IC, Gennetier A, Hernandez M, Carmona-Abellan M, Marcilla Garcia I, Kremer EJ, Luquin R. CAV-2-Mediated GFP and LRRK2 Expression in the Brain. Frontiers in Molecular Neuroscience. 13: 49. PMID 32269512 DOI: 10.3389/fnmol.2020.00049   
2020 Zhong J, Ye S, Zhou X, Huang J, Li X, Zhang S, Zhou J, Chen D, Li C. Plastrum Testudinis Extracts Promote NSC Differentiation into Dopaminergic Neuron by Regulating the Interaction of TET1 and FoxA2. Evidence-Based Complementary and Alternative Medicine : Ecam. 2020: 9104135. PMID 32382312 DOI: 10.1155/2020/9104135   
2020 Hou L, Qu X, Qiu X, Huang R, Zhao X, Wang Q. Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson's disease model. Journal of Neuroinflammation. 17: 148. PMID 32375810 DOI: 10.1186/s12974-020-01823-3   
2020 Kuter KZ, Cenci MA, Carta AR. The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications. Progress in Brain Research. 252: 131-168. PMID 32247363 DOI: 10.1016/bs.pbr.2020.02.004   
2020 Togashi K, Hasegawa M, Nagai J, Kotaka K, Yazawa A, Takahashi M, Masukawa D, Goshima Y, Hensley K, Ohshima T. Lanthionine ketimine ester improves outcome in an MPTP-induced mouse model of Parkinson's disease via suppressions of CRMP2 phosphorylation and microglial activation. Journal of the Neurological Sciences. 413: 116802. PMID 32244093 DOI: 10.1016/j.jns.2020.116802   
2020 Lang Y, Li Y, Yu H, Lin L, Chen X, Wang S, Zhang H. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2 miR-221-3p binding. Aging. 12. PMID 32396526 DOI: 10.18632/aging.103028   
2020 Lang Y, Li Y, Yu H, Lin L, Chen X, Wang S, Zhang H. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2 miR-221-3p binding. Aging. 12. PMID 32396526 DOI: 10.18632/aging.103028   
2020 Crans RAJ, Wouters E, Valle-León M, Taura J, Massari CM, Fernández-Dueñas V, Stove CP, Ciruela F. Striatal Dopamine D-Muscarinic Acetylcholine M Receptor-Receptor Interaction in a Model of Movement Disorders. Frontiers in Pharmacology. 11: 194. PMID 32231561 DOI: 10.3389/fphar.2020.00194   
2020 Ozbey G, Nemutlu-Samur D, Parlak H, Yildirim S, Aslan M, Tanriover G, Agar A. Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation. Pharmacological Reports : Pr. PMID 32207092 DOI: 10.1007/s43440-020-00095-1   
2020 Paredes-Rodriguez E, Vegas-Suarez S, Morera-Herreras T, De Deurwaerdere P, Miguelez C. The Noradrenergic System in Parkinson's Disease. Frontiers in Pharmacology. 11: 435. PMID 32322208 DOI: 10.3389/fphar.2020.00435   
2020 Mohammed N, Abdou H, Essawy A, Tass M, Alfwuaires M, Abdel-Moneim A. Oral Supplements of Ginkgo biloba Extract Alleviate Neuroinflammation, Oxidative Impairments and Neurotoxicity in Rotenone-Induced Parkinsonian Rats. Current Pharmaceutical Biotechnology. PMID 32196446 DOI: 10.2174/1389201021666200320135849   
2020 Miyazaki I, Isooka N, Imafuku F, Sun J, Kikuoka R, Furukawa C, Asanuma M. Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease. International Journal of Molecular Sciences. 21. PMID 32375371 DOI: 10.3390/ijms21093254   
2020 Elizabeth MA, Samson P, Itohan OR. Histomorphological evaluations on the frontal cortex extrapyramidal cell layer following administration of N-Acetyl cysteine in aluminum induced neurodegeneration rat model. Metabolic Brain Disease. PMID 32212044 DOI: 10.1007/s11011-020-00556-9   
2020 Soto-Rojas LO, Martínez-Dávila IA, Luna-Herrera C, Gutierrez-Castillo ME, Lopez-Salas FE, Gatica-Garcia B, Soto-Rodriguez G, Bringas Tobon ME, Flores G, Padilla-Viveros A, Bañuelos C, Blanco-Alvarez VM, Dávila-Ayala J, Reyes-Corona D, Garcés-Ramírez L, et al. Unilateral intranigral administration of β-sitosterol β-D-glucoside triggers pathological α-synuclein spreading and bilateral nigrostriatal dopaminergic neurodegeneration in the rat. Acta Neuropathologica Communications. 8: 56. PMID 32321590 DOI: 10.1186/s40478-020-00933-6   
2020 Diniz LP, Bérgamo Araujo AP, Matias I, Garcia MN, Aragão FB, Foguel D, Braga C, Figueiredo CP, Romão L, Gomes FCA. Astrocyte glutamate transporters are increased in an early sporadic model of synucleinopathy. Neurochemistry International. 104758. PMID 32439533 DOI: 10.1016/j.neuint.2020.104758   
2020 Xia ML, Xie XH, Ding JH, Du RH, Hu G. Astragaloside IV inhibits astrocyte senescence: implication in Parkinson's disease. Journal of Neuroinflammation. 17: 105. PMID 32252767 DOI: 10.1186/s12974-020-01791-8   
2020 Schonhoff AM, Williams GP, Wallen ZD, Standaert DG, Harms AS. Innate and adaptive immune responses in Parkinson's disease. Progress in Brain Research. 252: 169-216. PMID 32247364 DOI: 10.1016/bs.pbr.2019.10.006   
2020 Abato JE, Moftah M, Cron GO, Smith PD, Jadavji NM. Methylenetetrahydrofolate reductase deficiency alters cellular response after ischemic stroke in male mice. Nutritional Neuroscience. 1-9. PMID 32448097 DOI: 10.1080/1028415X.2020.1769412   
2020 Gonzalez-Rodriguez P, Zampese E, Surmeier DJ. Selective neuronal vulnerability in Parkinson's disease. Progress in Brain Research. 252: 61-89. PMID 32247375 DOI: 10.1016/bs.pbr.2020.02.005   
2020 Salehpour F, Hamblin MR. Photobiomodulation for Parkinson's Disease in Animal Models: A Systematic Review. Biomolecules. 10. PMID 32326425 DOI: 10.3390/biom10040610   
2020 Zhan X, Wen G, Jiang E, Li F, Wu X, Pang H. Secretogranin III upregulation is involved in parkinsonian toxin-mediated astroglia activation. The Journal of Toxicological Sciences. 45: 271-280. PMID 32404559 DOI: 10.2131/jts.45.271   
2020 Yu Y, Li L, Nguyen DT, Mustafa SM, Moore BM, Jiang J. Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics. Molecular Neurobiology. PMID 32378121 DOI: 10.1007/s12035-020-01923-4   
2020 Zhang ZL, Gao YG, Zang P, Gu PP, Zhao Y, He ZM, Zhu HY. [Research progress on mechanism of gastrodin and p-hydroxybenzyl alcohol on central nervous system]. Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica. 45: 312-320. PMID 32237313 DOI: 10.19540/j.cnki.cjcmm.20190730.401   
2020 Lee B, Yeom M, Shim I, Lee H, Hahm DH. Protective Effects of Quercetin on Anxiety-Like Symptoms and Neuroinflammation Induced by Lipopolysaccharide in Rats. Evidence-Based Complementary and Alternative Medicine : Ecam. 2020: 4892415. PMID 32419805 DOI: 10.1155/2020/4892415   
2020 Castela I, Hernández LF. Shedding light on dyskinesias. The European Journal of Neuroscience. PMID 32394612 DOI: 10.1111/ejn.14777   
2020 Dallé E, Daniels WMU, Mabandla MV. Long-Term Treatment with Fluvoxamine Decreases Nonmotor Symptoms and Dopamine Depletion in a Postnatal Stress Rat Model of Parkinson's Disease. Oxidative Medicine and Cellular Longevity. 2020: 1941480. PMID 32273939 DOI: 10.1155/2020/1941480   
2020 Sun Z, Ma X, Yang H, Chen S, He S, Sun R, Lu H, Zhang J. Characterization of age-dependent behavior deficits in the PGC-1α knockout mouse, in relevance to the Parkinson's disease model. Neuroscience. PMID 32439544 DOI: 10.1016/j.neuroscience.2020.05.015   
2020 Li W, Chen H, Xu Z, Lv Y, Zhao Z, Zhang J, Qu F. Melodinhenine B attenuates NLRP3 expression in a cerebral ischemia/reperfusion-induced neuronal injury rat model. Folia Neuropathologica. 58: 30-37. PMID 32337955 DOI: 10.5114/fn.2020.94004   
2020 Shaerzadeh F, Phan L, Miller D, Dacquel M, Hachmeister W, Hansen C, Bechtle A, Tu D, Martcheva M, Foster TC, Kumar A, Streit WJ, Khoshbouei H. Microglia senescence occurs in both substantia nigra and ventral tegmental area. Glia. PMID 32275335 DOI: 10.1002/glia.23834   
2020 Pallàs M, Vázquez S, Sanfeliu C, Galdeano C, Griñán-Ferré C. Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy. Biomolecules. 10. PMID 32369955 DOI: 10.3390/biom10050703   
2020 Barnhill LM, Khuansuwan S, Juarez D, Murata H, Araujo JA, Bronstein JM. Diesel exhaust extract exposure induces neuronal toxicity by disrupting autophagy. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 32298450 DOI: 10.1093/toxsci/kfaa055   
2020 Hsieh TH, Kuo CW, Hsieh KH, Shieh MJ, Peng CW, Chen YC, Chang YL, Huang YZ, Chen CC, Chang PK, Chen KY, Chen HY. Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson's Disease. Brain Sciences. 10. PMID 32244769 DOI: 10.3390/brainsci10040206   
2020 Liu C, Xue Y, Liu MF, Wang Y, Chen L. Orexin and Parkinson's disease: a protective neuropeptide with therapeutic potential. Neurochemistry International. 104754. PMID 32422324 DOI: 10.1016/j.neuint.2020.104754   
2020 Fasciani I, Petragnano F, Aloisi G, Marampon F, Rossi M, Coppolino MF, Rossi R, Longoni B, Scarselli M, Maggio R. A New Threat to Dopamine Neurons: The Downside of Artificial Light. Neuroscience. 432: 216-228. PMID 32142863 DOI: 10.1016/j.neuroscience.2020.02.047   
2020 Keller S, Polanski WH, Enzensperger C, Reichmann H, Hermann A, Gille G. 9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 32285253 DOI: 10.1007/s00702-020-02189-9   
2020 Cenci MA, Björklund A. Animal models for preclinical Parkinson's research: An update and critical appraisal. Progress in Brain Research. 252: 27-59. PMID 32247366 DOI: 10.1016/bs.pbr.2020.02.003   
2020 Sharma R, Kambhampati SP, Zhang Z, Sharma A, Chen S, Duh EI, Kannan S, Tso MOM, Kannan RM. Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32339548 DOI: 10.1016/j.jconrel.2020.04.036   
2020 Li HQ, Pratelli M, Godavarthi S, Zambetti S, Spitzer NC. Decoding Neurotransmitter Switching: The Road Forward. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 40: 4078-4089. PMID 32434858 DOI: 10.1523/JNEUROSCI.0005-20.2020   
2020 Wang QJ, Chen AD, Chen HC, Wang DX, Cai YT, Yin J, Jing YH, Gao LP. Noncanonical Roles of h-syn (A53T) in the Pathogenesis of Parkinson's Disease: Synaptic Pathology and Neuronal Aging. Neural Plasticity. 2020: 6283754. PMID 32273890 DOI: 10.1155/2020/6283754   
2020 Sinen O, Bülbül M, Derin N, Ozkan A, Akcay G, Aslan MA, Agar A. The effect of chronic neuropeptide-S treatment on non-motor parameters in experimental model of Parkinson's disease. The International Journal of Neuroscience. 1-10. PMID 32441169 DOI: 10.1080/00207454.2020.1754213   
2020 Zhang ZW, Liang J, Yan JX, Ye YC, Wang JJ, Chen C, Sun HT, Chen F, Tu Y, Li XH. TBHQ improved neurological recovery after traumatic brain injury by inhibiting the overactivation of astrocytes. Brain Research. 146818. PMID 32275911 DOI: 10.1016/j.brainres.2020.146818